Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
70
ONC Quote, Financials, Valuation and Earnings
Last price:
$290.34
Seasonality move
:
9.42%
Day range:
$287.33 - $298.00
52-week range:
$148.81 - $287.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.17x
P/B ratio:
8.63x
Volume:
489.3K
Avg. volume:
374.8K
1-year change:
88.98%
Market cap:
$30.2B
Revenue:
$3.8B
EPS (TTM):
-$3.77
Earnings Data
Next earnings date for ONC
Aug 06
2025
Most recent earnings per share
--
Beat by $0.74
(May 7/2025)
Consensus Estimate
-$0.74
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ONC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $1.3B | -- | -- | $0.34 | -- |
| 08/06/2025 | Q2 | $1.2B | -- | -- | $0.26 | -- |
| 05/07/2025 | Q1 | $1.1B | $1.1B | -- | -$0.74 | -- |
| 02/27/2025 | Q4 | $1B | $1.1B | -$1.43 | -$1.02 | -$0.41 |
| 11/12/2024 | Q3 | $984.2M | $1B | -$1.17 | -$1.11 | -$0.06 |
| 06/30/2024 | Q2 | $809.2M | $929.2M | -$1.17 | -$2.14 | $0.97 |
| 03/31/2024 | Q1 | $675.2M | $751.7M | -$2.47 | -$2.54 | $0.07 |
| 12/31/2023 | Q4 | $638.3M | $634.4M | -$3.51 | -$3.45 | -$0.06 |
| 09/30/2023 | Q3 | $578.2M | $781.3M | $1.95 | -$2.93 | $4.88 |
| 06/30/2023 | Q2 | $515.4M | $595.3M | -$3.64 | -$2.98 | -$0.66 |
| 03/31/2023 | Q1 | $449.4M | $447.8M | -$3.38 | -$3.66 | $0.28 |
| 12/31/2022 | Q4 | -- | $380.1M | -$4.29 | -- | -- |
| 09/30/2022 | Q3 | -- | $387.6M | -$5.33 | -- | -- |
| 06/30/2022 | Q2 | -- | $341.6M | -$5.46 | -- | -- |
| 03/31/2022 | Q1 | -- | $306.6M | -$4.29 | -- | -- |
| 12/31/2021 | Q4 | -- | $214M | -$6.11 | -- | -- |
| 09/30/2021 | Q3 | -- | $206.4M | -$4.72 | -- | -- |
| 06/30/2021 | Q2 | -- | $150M | -$5.23 | -- | -- |
| 03/31/2021 | Q1 | -- | $605.9M | $0.65 | -- | -- |
| 12/31/2020 | Q4 | -- | $100.1M | -$5.20 | -- | -- |
| 09/30/2020 | Q3 | -- | $91.1M | -$4.81 | -- | -- |
| 06/30/2020 | Q2 | -- | $65.6M | -$4.29 | -- | -- |
| 03/31/2020 | Q1 | -- | $52.1M | -$4.70 | -- | -- |
| 12/31/2019 | Q4 | -- | $56.9M | -$6.37 | -- | -- |
| 09/30/2019 | Q3 | -- | $50.1M | -$5.07 | -- | -- |
| 06/30/2019 | Q2 | -- | $243.3M | -$1.43 | -- | -- |
| 03/31/2019 | Q1 | -- | $77.8M | -$2.86 | -- | -- |
| 12/31/2018 | Q4 | -- | $58.7M | -$4.55 | -- | -- |
| 09/30/2018 | Q3 | -- | $54.2M | -$2.47 | -- | -- |
| 06/30/2018 | Q2 | -- | $52.8M | -$2.86 | -- | -- |
| 03/31/2018 | Q1 | -- | $32.5M | -$2.08 | -- | -- |
| 12/31/2017 | Q4 | -- | $18.2M | -$2.18 | -- | -- |
| 09/30/2017 | Q3 | -- | $220.2M | $2.60 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$1.56 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$1.30 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.95 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$1.04 | -- | -- |
| 06/30/2016 | Q2 | -- | $393K | -$0.78 | -- | -- |
| 03/31/2016 | Q1 | -- | $677K | -$0.91 | -- | -- |
| 12/31/2015 | Q4 | -- | $4.7M | -$0.86 | -- | -- |
| 09/30/2015 | Q3 | -- | $1.4M | -$0.26 | -- | -- |
BeOne Medicines Earnings Questions
-
How Much did BeOne Medicines Generate in Revenue Last Quarter?
BeOne Medicines reported $1.1B worth of top line sales in its most recent quarter.
-
Did BeOne Medicines Beat Earnings Last Quarter?
BeOne Medicines announced earnings per share of -- which represents a beat of analyst forecast a -$0.74 per share.
-
Is BeOne Medicines Profitable?
BeOne Medicines reported $952.3M that represents $8.57 per share over the last quarter.
-
What is the Analyst Consensus for BeOne Medicines EPS Next Year?
BeOne Medicines's earnings are forecast to decrease from -$6.11 per share to -$5.69 per share next year representing a decrease of -98.91%.
-
When is BeOne Medicines's Earnings Date?
BeOne Medicines's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
